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Due to a lack of early symptoms, pancreatic cancers of the body and tail are discovered mostly at advanced stages. These locally
advanced cancers often involve the celiac axis or the common hepatic artery and are therefore declared unresectable. The extended
distal pancreatectomy with en bloc resection of the celiac artery may oﬀer a chance of complete resection. We present the case of
a 48-year-old female with pancreatic body cancer invading the celiac axis. The patient underwent laparoscopy to exclude hepatic
and peritoneal metastasis. Subsequently, a selective embolization of the common hepatic artery was performed to enlarge arterial
ﬂow to the hepatobiliary system and the stomach via the pancreatoduodenal arcades from the superior mesenteric artery. Fifteen
days after embolization, the extended distal pancreatectomy with splenectomy and en bloc resection of the celiac axis was carried
out. The postoperative course was uneventful, and complete tumor resection was achieved. This case report and a review of
the literature show the feasibility and safety of the extended distal pancreatectomy with en bloc resection of the celiac axis. A
preoperative embolization of the celiac axis may avoid ischemia-related complications of the stomach or the liver.
1.Introduction
Pancreatic adenocarcinoma is still a tumor entity with a
poor prognosis and an overall long-term survival of 1–5%
[1, 2]. A major problem is its early detection since 80–90%
of the pancreatic cancers are locally or systemically advanced
at the time of diagnosis [2–4] .D e s p i t er e c e n ta d v a n c e si n
chemotherapy, complete resection remains the only chance
for cure [3, 5]. Thus, ﬁve-year survival rates of about 25%
are observed if patients underwent surgery [2]. Especially
cancers of the body and tail of the pancreas are discovered
mostly at advanced stages due to a lack of early symptoms;
for example, obstructive jaundice which is caused by cancers
oftheheadofthepancreas.Theselocallyadvancedcancersof
thebodyandtailofteninvolvemajorvesselssuchastheceliac
axis or the common hepatic artery [6]. Hence the tumors
are declared unresectable in spite of the absence of distant
metastasis.
The standard resection for tumors of the body and tail
of the pancreas is a distal pancreatectomy with concomi-
tant splenectomy [7]. Distal pancreatectomy with en bloc
resection of the celiac artery has broadened the operative
spectrum in pancreatic surgery. First reported by Appleby in
1953 to achieve complete nodal clearance around the celiac
artery for advanced gastric cancer, Nimura adopted this
approach, for advanced cancers of the pancreatic body [6, 8].
Since then just a few of these procedures have been described
and due to the small number of patients, the overall survival
beneﬁt is still unknown [9–11]. We present the case of a
48-year-old female with pancreatic body cancer invading2 Case Reports in Medicine
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Figure 1: (a) Preoperative arterial phase contrast-enhanced CT scan showing a 3.3cm lesion in the body of the pancreas. (b) The coronary
slice displays tumor inﬁltration of the celiac trunk, and the superior mesenteric artery is not involved.
(a) (b)
Figure 2: (a) Embolization of the celiac axis with an 8mm Amplatzer vascular plug 4. (b) The immediate angiographic control after
embolization shows a collateral circulation from the superior mesenteric artery via the pancreatoduodenal arcades to the gastroduodenal
artery. This ensures suﬃcient arterial ﬂow to the right gastroepiploic artery (arrow) and the proper hepatic artery (arrowhead).
the celiac axis treated by preoperative embolization and
subsequentextendeddistalpancreatectomyandsplenectomy
with en bloc resection of the celiac axis.
2. Case Presentation
A 48-year-old otherwise healthy woman had suﬀered epi-
gastric and back pain for 4 weeks. At ﬁrst, gastroscopy
was performed showing no pathological ﬁndings. Subse-
quent contrast-enhanced computed tomography depicted a
3.3cm lesion in the body of the pancreas with invasion
of the celiac axis (Figure 1(a)). Therefore, the tumor was
declared unresectable in an external hospital, and a pal-
liative chemotherapy with gemcitabine and erlotinib was
initiated. After 3 cycles of chemotherapy, she presented
to our clinic to be reassessed. We carefully reviewed the
ﬁndingsandagreedasurgicalapproachwithher.Thepatient
underwent laparoscopy to exclude hepatic and peritoneal
metastasis. Subsequently a selective embolization of the
common hepatic was performed. First celiac and superior
mesenteric artery angiograms were obtained to conﬁrm
the presence of the pancreatoduodenal arcade. Thereafter,
a 6F sheath was placed in the common hepatic artery.
After the identiﬁcation of the origin of the gastroduodenal
artery an 8mm Amplatzer vascular plug 4 (AGA Medical
Corp., Plymouth, MN USA) was placed in the common
hepatic artery (Figure 2(a)). Completion angiograms of the
celiac trunk and the superior mesenteric artery conﬁrmed
complete occlusion of the common hepatic artery and
retrograde arterial perfusion of the liver and the stomach
through the pancreatoduodenal arcade (Figure 2(b)).
Fifteen days after embolization of the celiac axis, the
extended distal pancreatectomy with splenectomy and en
bloc resection of the celiac axis was carried out. We favour
an upper abdominal transverse incision with extension toCase Reports in Medicine 3
the xiphoid to ensure maximum visibility and access to
the pancreas. After conﬁrming the absence of hepatic and
peritoneal metastasis, the superior mesenteric artery was
exposedatitsoriginfromtheaortatoexcludetumorinﬁltra-
tion. The patient underwent a prophylactic cholecystectomy
to avoid postoperative ischemic cholecystitis. The hepato-
duodenal ligament was dissected, and the proper hepatic
artery, the common hepatic artery, and the gastroduodenal
artery were exposed. After the common hepatic artery was
divided proximally to the origin of the gastroduodenal
artery, an excellent pulsation of the left and right hepatic
artery was still assessed. The pancreas was transected at the
level of the portal vein. The dissection of the portal vein
revealed a potential tumor inﬁltration at the splenic vein
conﬂuence; thus, a concomitant portal vein wedge resection
was performed. Then the origin of the celiac artery was
identiﬁedabovethesuperiormesentericartery,andtheceliac
artery and the left gastric artery were divided. The body
and tail of the pancreas, the spleen, the celiac axis, and the
surrounding lymph nodes and nerve plexus were removed
en bloc (Figure 3). Finally, the pancreatic duct was ligated
separately and the pancreatic head stump was oversewn
with nonabsorbable suture material. The operation lasted
195min, the intraoperative blood loss was 350mL, and no
red blood cell transfusions were required.
The postoperative course went uneventful, and the
patient was discharged after 20 days stay in the hospital.
A postoperative CT scan revealed suﬃcient arterial ﬂow
of the hepatic arteries via the pancreatoduodenal arcades
(Figure 4). A moderate increase of the serum concentrations
of alanine aminotransferase and aspartate aminotransferase
returned to normal ranges within the hospital stay. A post-
operative diarrhoea or ischemic gastropathy did not occur.
Additionally, the patient did not develop a pancreoprivic
diabetes mellitus. The postsplenectomy vaccine prophylaxis
against Streptococcus pneumoniae, Haemophilus inﬂuenzae
type B, and Neisseria meningitidis was administered during,
the hospital stay.
The histopathologic ﬁndings showed an invasive ductal
adenocarcinoma of the pancreas (pT3) with a size of
6cm and clear histologically surgical margins (R0). The
histopathologic grading was G2 (moderately diﬀerentiated),
and two regional lymph node metastases were detected
(2/17). A notable perineural inﬁltration extending to the
celiac plexus was present. On the recommendation of the
interdisciplinary gastrointestinal tumor board, a postoper-
ative chemotherapy with gemcitabine (1000mg/m2 for 3
weeks of a 4-week cycle for 6 months) was carried out.
After treatment completion no local recurrence and distant
metastasis occurred as evaluated by CT scan.
3. Discussion
Due to late presentation of symptoms, more than 75%
of carcinomas of the body and tail of the pancreas are
considered unresectable at the time of diagnosis [12–14].
The most common reasons are the presence of hepatic
metastases, peritoneal dissemination of tumor, or the direct
Figure 3: Operative photograph taken after the removal of the
specimen. 1: head of the pancreas, 2: portal vein, 3: superior
mesenteric vein, 4: gastroduodenal artery, and 5: celiac axis stump.
Figure 4: The postoperative arterial contrast-enhanced CT scan
shows an excellent arterial ﬂow to the hepatobiliary system via
gastroduodenal artery and pancreatoduodenal arcades from the
superior mesenteric artery.
invasion of major vascular structures, respectively. Venous
resections including the portal and superior mesenteric vein
are well-accepted procedures, while tumor invasion of the
superior mesenteric artery or the celiac axis is regarded
as a contraindication for a surgical approach [1, 2]. This
rejection is due to previously reported high mortality and
poor prognosis after resection of arterial vessels [3, 15].
Shouldatumorinvasionofthecommonhepaticarteryorthe
celiac axis be indeed a general contraindication to resection?
Consequentially, these patients, as seen in our case report,
would receive chemotherapy in a palliative intention with an
approximately median survival of only 6 months [16].
Since Nimura implemented the distal pancreatectomy
with en bloc resection of the celiac axis in 1976, a few
authors have performed this procedure successfully [9–
11]. Due to the small number of patients, the overall
survival beneﬁt remains unclear. Hirano et al. report an
estimated overall 1- and 5-year survival rate of 71% and
42%, respectively, and the median survival was 21.0 months
[10]. Mayumi et al. compared the outcome of 47 patients
with carcinoma of the pancreatic body or tail [9]. Six cases
underwent an extended distal pancreatectomy with en bloc
resection of the celiac axis, 19 cases received a standard
distal pancreatectomy, and a third group consisted of 22
patients with unresectable pancreatic adenocarcinoma. The4 Case Reports in Medicine
cumulative 1- and 3-year accumulated survival rates for
the extended, standard, and unresectable groups were 40.0,
33.3, and 5.4, and 20.0, 16.6, and 0%, respectively. Wu
et al. compared 31 patients with invasion of the common
hepatic artery or celiac axis: 11 patients, who received a distal
pancreatectomy with en bloc resection of the celiac axis, to
20 patients, who did not undergo surgery [11]. The ﬁrst
group had a signiﬁcantly prolonged median survival time
compared with the second group (14 versus 5 months, P =
0.013). However, estimated 5-year survival rates of 42% as
reported by Hirano et al. [10]m u s tb er e a dw i t hc a u t i o nd u e
to the small number of patients. But a median survival time
of 21.0 months is excellent in cases that have previously been
considered unresectable. The distal pancreatectomy with en
bloc resection of the celiac axis can achieve a R0 resectability
rate of 91% [10]. It is well known that a complete tumor
resection with negative surgical margins is an important
independent prognostic factor for survival [13] and the only
chance for cure [3, 5]. Hence, a surgical approach is justiﬁed
in selected cases with advanced pancreatic cancers.
Additionally, this operation not only increases the
resectability but also improves quality of life due to long-
lasting pain relief [11, 17]. Advanced pancreatic adeno-
carcinoma frequently involves nervous tissue and spreads
along nerve ﬁbers [18, 19]. The cancer involvement of the
celiac plexus and celiac ganglions results in intractable pain,
and medical treatment is often unsuccessful [17]. Thus
new techniques including celiac plexus block [17, 20, 21],
intrathecal morphine administration via a subcutaneous
pump [22], or thoracoscopic splanchnicectomy [23]h a v e
been developed. However complete pain relief is diﬃcult to
achieve. Hirano et al. report a complete pain relief in all
10 patients with preoperative intractable pain after distal
pancreatectomy with en bloc resection of the celiac axis
[10]. Because radical distal pancreatectomy with en bloc
resection of the celiac axis includes complete removal of
the celiac plexus and celiac ganglions, it is understandable
that the operative procedure results in excellent pain control
[6, 17, 24].
Despite these advantages the high morbidity rate of
the distal pancreatectomy with en bloc resection of the
celiac axis must be considered. Hirano et al. report a
morbidity rate of 48% in a series with 23 patients [10]. The
mainpostoperativecomplicationswerepancreaticﬁstulaand
ischemic gastropathy [10, 25, 26]. An arterial reconstruction
is mostly dispensable because collateral pathways via the
superior mesenteric artery, pancreatoduodenal arcades, and
gastroduodenal artery maintain the arterial blood supply
for the hepatobiliary system [6]. The entire stomach can be
preserved because collateral pathways ensure arterial ﬂow
also to the right gastroepiploic artery [6]. A preoperative
embolization of the celiac axis may prevent ischemia-related
complications of the stomach or the liver by enlarging these
collateral pathways from the superior mesenteric artery.
Hirano et al. noticed a remarkable decrease of ischemic
gastropathy to an incidence of 13% after the introduction of
the preoperative coil embolization [10]. Therefore, we also
performed an embolization of the celiac axis 15 days prior
to the operation. Previously published case series report a
waiting period between embolization and surgery of 1–29
days [10, 27, 28]. Although there is no reliable evidence base
available regarding length of waiting period after emboliza-
tion, we have some knowledge from studies concerning
preoperative gastric conditioning prior to esophagectomy.
Bludau et al. found that gastric mucosal oxygen saturation,
which drops signiﬁcantly with devascularization of the
stomach, nearly returns to baseline levels by 4-5 days [29].
A study by Veeramootoo et al. on gastric conduit reported
that ischemic preconditioning 2 weeks before surgery was
associatedwithlessischemia-relatedgastricfailurecompared
t o5d a y sp r i o rt os u r g e r y[ 30]. However, the ideal timing
needs to be further ascertained.
During surgery the key vessel of the distal pancrea-
tectomy with en bloc resection of the celiac axis is the
inferior pancreatoduodenal artery from the superior mesen-
teric artery, and surgeons should identify this artery to
avoid an accidental injury. If an arterial reconstruction is
needed, a middle colic artery-gastroepiploic artery bypass
can be used [10]. The splenic artery, which can be taken
from the resected specimen, is another suitable option for
reconstruction [26]. We performed a staging laparoscopy
before coil embolization of the celiac axis to conﬁrm absence
of metastatic disease. Approximately 40–50% of the patients
have distant metastases at the time presentation [2, 31, 32].
Despite advances of imaging technology, noninvasive staging
modalities are still inaccurate in identifying small volume
metastatic disease [32]. A staging laparoscopy may reveal
these unsuspected metastases and prevent unnecessary coil
embolization and laparotomy.
This case report and the cited studies display the feasi-
bility and safety of the operation. The encouraging results of
Hirano et al. [10], who reported a median survival time of
21 months, cannot hide the fact that distal pancreatectomy
with en bloc resection of the celiac axis on its own cannot
achieve a favorable long-term survival. Despite the excellent
local control achieved through this procedure, early hepatic
recurrence still persists [10]. The adjuvant treatment as a
postoperative chemotherapy seems to be a key factor to
further improve patient survival [2].
4. Conclusion
The extended distal pancreatectomy with en bloc resection
of the celiac axis following a preoperative embolization
provides a high resectability rate and a long-lasting pain
relief. These results justify further evaluation of the long-
term survival beneﬁts. However, this procedure should
alwaysbeconsideredinpatientswithlocallyadvancedcancer
of the pancreatic body or tail involving the celiac axis or the
common hepatic artery. The presentation of these patients
t oah i g hv o l u m ec e n t e ro fp a n c r e a t i cs u r g e r ym a ya v o i d
premature palliative chemotherapy.
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